CoChat

Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double‐blind, placebo‐controlled studies

Davidson, Jonathan, Allgulander, Christer, Pollack, Mark H., Hartford, James, Erickson, Janelle S., Russell, James M., Perahia, David, Wohlreich, Madalaine M., Carlson, Janice, Raskin, Joel · 2008 · Human Psychopharmacology: Clinical and Experimental
Cited by 57

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Objective: To assess the efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder (GAD). Methods: Acute‐phase data from a subset of patients (≥65 years) with GAD were pooled from four randomized, double‐blind, placebo‐controlled trials of duloxetine (3 flexible, 1 fixed dosing). Patients were treated with duloxetine 60–120 mg once daily or placebo for 9–10 weeks. The primary outcome measure was the mean baseline‐to‐endpoint change in Hamilton anxiety scale (HAMA) total score. Secondary measures included the HAMA psychic and somatic anxiety subscales and the Hospital Anxiety Depression Scale (HADS). Results: Of 1491 patients randomly assigned to treatment, 4.9% (duloxetine, n = 45; placebo, n = 28) were ≥ 65 years old. Compared with placebo‐treated patients, duloxetine‐treated patients experienced significantly greater improvements on the HAMA‐total (p = 0.029), the HAMA‐psychic anxiety factor (p = 0.034), HADS‐anxiety (p = 0.049) and ‐depression scales (p = 0.026), but not the HAMA somatic anxiety factor (p = 0.074). Nausea was reported significantly more often in duloxetine‐treated patients (30.0% vs. 7.1%, p = 0.023); duloxetine‐treated patients experienced greater weight loss (p = 0.018). More duloxetine‐treated patients discontinued treatment due to an adverse event (22.2% vs. 0%; p = 0.006). Conclusion: Duloxetine was effective in an elderly patient subset with GAD, although there was a high rate of discontinuations due to adverse events. Copyright © 2008 John Wiley & Sons, Ltd.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hup.949

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 57

Metadata

Authors
Davidson, J., Allgulander, C., Pollack, M. H., Hartford, J., Erickson, J. S., Russell, J. M., Perahia, D., Wohlreich, M. M., Carlson, J., & Raskin, J.
Venue
Human Psychopharmacology: Clinical and Experimental
Publisher
Wiley
Published
2008-05-14
Volume
23
Issue
6
Pages
519-526
ISSN
  • 0885-6222 (ISSN-L)
  • 1099-1077
OpenAlex
W2098344591
Cited by
57
References
7
FWCI
9.12
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.